Susquehanna International Group’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32M Sell
117,000
-195,200
-63% -$2.15M ﹤0.01% 7187
2025
Q4
$2.5M Buy
+312,200
New +$7.3M ﹤0.01% 5195
2022
Q2
Sell
-242
Closed -$26K 13460
2022
Q1
$26K Buy
242
+4
+2% +$764 ﹤0.01% 12545
2021
Q4
$61K Sell
238
-1,046
-81% -$318K ﹤0.01% 12445
2021
Q3
$453K Sell
1,284
-2,018
-61% -$794K ﹤0.01% 9645
2021
Q2
$1.64M Sell
3,302
-4,034
-55% -$1.97M ﹤0.01% 6394
2021
Q1
$3.48M Buy
7,336
+5,528
+306% +$10.7M ﹤0.01% 4647
2020
Q4
$3.19M Buy
+1,808
New +$2.39M ﹤0.01% 4206

Other funds holding KRRO

Susquehanna International Group's KRRO Position: Q1 2026 in Review

Susquehanna International Group sold out of Korro Bio (KRRO) in Q1 2026, closing a stake of 196,827 shares — an estimated $2.17M sold.

Susquehanna International Group first reported a position in KRRO in Q3 2020 and held it in 13 quarters. The position peaked at $1.58M in Q4 2025. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Susquehanna International Group reported no remaining Korro Bio position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 196,827 Korro Bio shares in Q1 2026, an estimated $2.17M.
  • Susquehanna International Group first reported a position in Korro Bio in Q3 2020 and held it in 13 quarters.
  • Susquehanna International Group's Korro Bio position peaked at $1.58M in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.